References
- Proceedings of the International Symposium on Cyclodextrins. Sept. -Oct., 301981. Budapest, Hungary
- Wojcik J. F., Rohebach R. P. J. Phys. Chem. 1975; 79: 2251, as cited by Saenger, W., in “Cyclodextrin Inclusion Compounds in Research and Industry”, Angew. Chem. Int. Ed. Elg. 19, 344–363 (1980
- Fujimoto S., Japan Kokai 78. 607, 1978, as cited by Szoke, A.S., in “A Forecast for Application of Cyclodextrins in Pharma-Industry”, Int. Symp. on Cyclodextrins, Budapest, 377–387 (1981)
- Szetli J., Szente L. “Interaction of Indomethacin and β-CD”. Pharmazie 1981; 36: 694–698
- Lach J. L., Chin T. F. “Schardinger Dextrin Interaction, IV. Inhibition of Hydrolysis By Means of Molecular Complex Formation”. J. Pharm. Sci. 1987; 53: 924–927
- Kata M., Kedvessy G. “Increasing the Solubility Characteristics with Cyclodextrins”. Pharm. Ind. 1987; 49: 98–100
- Higuchi T., Lach J. L. “Investigation of Some Complexes formed in Solution by Caffeine. IV. Caffeine and Sulfathiazole, Sulfadiazine, p-Aminobenzoic Acid, Benzocaine, Phenobarbital and Barbital”. J. Amer. Pharm. Assn. 1954; XLIII: 349–354, 6
- Connors K. A., Mollica A. J. “Theoretical Analysis of Comparative Studies of Complexation”. J. Pharm. Sci. 1966; 55: 772–780